Lumir Inc. (474170.KQ) stock: key figures, P/E, revenue and dividend
Industrials · South Korea
Lumir Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 14.28 bn KRW | 10.57 bn KRW |
| Gross profit | 1.63 bn KRW | 2.25 bn KRW |
| Operating income | -1.20 bn KRW | -594.39 m KRW |
| EBIT | -1.14 bn KRW | 64.95 m KRW |
| Net income | -1.14 bn KRW | 45.66 m KRW |
| Diluted EPS – continuing operations | -64.58 KRW | 2.56 KRW |
Full history since 2022, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Lumir Inc.
Lumir Inc. engages in the satellite system development business in South Korea. It develops small synthetic aperture radar (SAR) satellite system; CAS500-5 C-band SAR satellite system; small SAR payload; Ka-band transmitter and phased array antenna; space internet communication device for lunar exploration; image data handling unit; on-board computer; Control Moment Gyro Controller; and Solenoid for marine engine fuel control valve. The company also operates SARDIP Web Platform that offers search, purchase, and analysis services. In addition, it provides SAR Level-1 image processing; AI-powered object detection; disaster damage analysis; urban change monitoring; and water resource facility safety management solutions. The company was formerly known as J&M System Co., Ltd and changed its name to Lumir Inc. in September 2016. Lumir Inc. was founded in 2009 and is headquartered in Yongin-si, South Korea.
More stocks
- CANTOURAGE GROUP SE O.N. (HIGH.F)
- Nanoform Finland Plc (NANOFH.HE)
- MARX Biotech Co., Ltd. (7731.TWO)
- LION COPPER & GOLD CORP. (LCGMF)
- TECOGEN INC. (TGEN)
- Evertex Fabrinology Ltd (1470.TW)
- Midnight Sun Mining Corp (MMA.V)
- Apex Science & Engineering Corp (3052.TW)
- Heidmar Maritime Holdings Corp. Common Stock (HMR)
- DreamCIS Inc (223250.KQ)
- Hyundai E P (089470.KS)
- Taiwan Bio Therapeutics Co., Ltd (6892.TWO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.